Bayer CropScience Ltd Share Price ₹4,248

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Bayer CropScience Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	982	1,740	1,617	955	792	1,631	1,738	1,057	1,046	1,915	1,553	1,106	1,101
Expenses +	777	1,315	1,312	827	695	1,317	1,554	1,037	876	1,566	1,348	989	898
Operating Profit	206	425	305	128	97	314	184	20	171	348	205	117	203
OPM %	21%	24%	19%	13%	12%	19%	11%	2%	16%	18%	13%	11%	18%
Other Income +	24	21	16	15	29	27	24	32	37	19	14	16	47
Interest	7	8	4	3	5	4	3	4	6	5	4	5	6
Depreciation	27	31	12	15	16	22	14	15	34	27	14	15	38
Profit before tax	195	406	306	124	105	316	190	34	168	335	200	113	206
Tax %	19%	19%	27%	25%	9%	20%	28%	-2%	15%	17%	24%	15%	21%
Net Profit +	158	328	223	93	96	254	136	34	143	279	153	96	162
EPS in Rs	35.27	73.09	49.60	20.72	21.36	56.56	30.33	7.61	31.89	62.01	33.98	21.29	36.07

Financials of Bayer CropScience Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	3,660	2,769	2,803	2,710	3,167	3,609	4,261	4,734	5,140	5,106	5,473	5,675
Expenses +	3,144	2,334	2,389	2,300	2,684	2,883	3,450	3,923	4,216	4,147	4,783	4,801
Operating Profit	516	435	414	410	483	726	812	812	924	959	691	874
OPM %	14%	16%	15%	15%	15%	20%	19%	17%	18%	19%	13%	15%
Other Income +	88	82	70	39	51	-64	69	112	168	76	118	95
Interest	5	10	7	11	10	14	13	13	22	20	17	20
Depreciation	25	25	29	33	44	65	74	64	80	74	85	94
Profit before tax	574	482	448	404	480	583	794	847	990	941	707	855
Tax %	33%	35%	35%	26%	30%	19%	38%	24%	23%	21%	20%	19%
Net Profit +	383	315	291	300	337	474	493	645	758	740	568	689
EPS in Rs	104.59	89.13	82.31	87.41	98.18	105.58	109.72	143.58	168.71	164.77	126.38	153.35
Dividend Payout %	20%	19%	21%	21%	18%	24%	105%	104%	77%	85%	99%	39%

Financials of Bayer CropScience Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	37	35	35	34	34	45	45	45	45	45	45	45
Reserves	1,996	1,804	2,021	1,744	2,205	2,528	2,505	2,479	2,667	2,804	2,806	2,921
Borrowings +	0	0	0	0	0	2	26	86	74	47	105	82
Other Liabilities +	740	597	769	756	1,310	1,262	1,663	1,742	1,893	1,701	2,290	2,652
Total Liabilities	2,773	2,437	2,825	2,535	3,549	3,836	4,239	4,353	4,679	4,597	5,246	5,699
Fixed Assets +	322	290	342	334	440	468	425	468	462	414	470	581
CWIP	1	17	24	36	47	56	76	98	109	119	119	5
Investments	29	68	50	0	0	41	52	38	41	54	35	57
Other Assets +	2,422	2,062	2,410	2,164	3,062	3,270	3,686	3,749	4,066	4,010	4,622	5,056
Total Assets	2,773	2,437	2,825	2,535	3,549	3,836	4,239	4,353	4,679	4,597	5,246	5,699

Financials of Bayer CropScience Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	200	206	157	121	433	666	687	216	609	952	262
Cash from Investing Activity +	485	16	-8	38	-113	-29	7	64	83	0	86
Cash from Financing Activity +	-42	-590	-73	-581	-158	-148	-556	-703	-613	-656	-619
Net Cash Flow	644	-367	76	-421	162	489	138	-424	79	296	-272
Free Cash Flow	297	170	108	80	378	638	656	168	537	912	222
CFO/OP	76%	86%	74%	53%	132%	110%	105%	59%	92%	113%	61%

Financials of Bayer CropScience Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	57	53	72	89	81	73	65	77	69	69	63	72
Inventory Days	85	169	178	175	294	206	226	235	268	222	319	231
Days Payable	40	52	67	67	164	101	142	127	129	87	148	134
Cash Conversion Cycle	102	171	184	197	211	177	149	185	208	204	234	169
Working Capital Days	53	92	104	134	116	77	61	84	86	78	88	60
ROCE %	31%	25%	23%	22%	25%	30%	31%	31%	34%	34%	25%	29%